Condition

Hematologic Neoplasms clinical trials and research

• 16Clinical trials
• 13Countries

Newest Hematologic Neoplasms clinical trials

All recruiting trials (16)

• Anti-CD25 antibody to prevent acute GVHD after haploidentical stem cell transplant

  This study tests whether an anti-CD25 antibody can better prevent acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation compared with the usual methotrexate-based approach.

  Recruiting Phase 3 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07689630

• KK2430 in people with hematologic cancers

  This study tests KK2430 in adults with blood-related cancers to see if it is safe and how it behaves in the body, with the goal of understanding its potential to help in treatment.

  Recruiting Phase 1/2 Kyowa Kirin Co., Ltd. · Greenville, South Carolina · NCT07629726

• JNJ-95804306 in relapsed or refractory blood cancers

  This study tests JNJ-95804306 in people with relapsed or refractory hematologic cancers to find a safe dose and see if it helps control the disease when given alone or with standard therapy.

  Recruiting at 19 sites Phase 1 Janssen Research & Development, LLC · Indianapolis, Indiana and 18 other locations · NCT07572006

• AI-written plain-language discharge summaries for people with blood and other cancers

  This project tests whether AI-written plain-language discharge letters help adults with hematologic or other cancers understand their diagnosis, treatment, and next steps better than the usual medical letter.

  Recruiting Technical University of Munich · Munich, Bavaria · NCT07519811

• Flu vaccine strategies for adults with blood cancers

  This study will test three different flu vaccines to see which gives the strongest antibody and T-cell responses in adults with blood cancers, including people after autologous stem cell transplant or CAR-T therapy.

  Recruiting Phase 3 Asan Medical Center · Seoul · NCT07485855

• Combining donor-derived anti-CD19 CAR-T cells with haploidentical transplant using post-transplant cyclophosphamide

  This trial tests whether giving donor-derived anti-CD19 CAR-T cells together with a haploidentical bone marrow transplant using post-transplant cyclophosphamide can help adults (18–75) with high‑risk CD19+ blood cancers.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07162038

• Investigation of family health in cancer patients and their caregivers

  This study looks at how cancer affects the health and well-being of patients with breast, prostate, colorectal cancers, and blood cancers, along with their caregivers, to see what support they need during treatment and recovery.

  Recruiting Odense University Hospital · Odense C · NCT06433349

• Validation of the OHI Index for Hematologic Malignancies

  This study is testing a new index to see if it can help doctors better understand and predict outcomes for patients with blood cancers who might develop a serious condition called HLH.

  Recruiting at 2 sites Meir Medical Center · Kfar Saba and 1 other locations · NCT05882175

• Infusing donor lymphocytes after blood cancer transplants to reduce relapse risk

  This study tests if giving special immune cells from a donor to patients with high-risk blood cancers after a transplant can help lower the chance of their cancer coming back.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT05327023

• Reducing cyclophosphamide doses for older or unfit patients undergoing bone marrow transplants

  This study is testing if giving a lower dose of cyclophosphamide can help older or less fit patients with blood cancers have a safer bone marrow transplant by reducing the risk of complications.

  Recruiting at 2 sites Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT04959175

• Exploring the role of microbiome in cancer patients undergoing high-dose chemotherapy and stem cell transplantation

  This study is trying to see how changes in the gut bacteria of cancer patients receiving high-dose chemotherapy and stem cell transplants might affect their recovery and risk of complications.

  Recruiting National Cancer Institute, Slovakia · Bratislava, Slovakia · NCT04691284

• Using Tranexamic Acid to Reduce Platelet Transfusions in Stem Cell Transplant Patients

  This study is testing if giving Tranexamic Acid along with platelet transfusions can help stem cell transplant patients need fewer transfusions and stay safer during their treatment.

  Recruiting at 8 sites Phase 3 Ottawa Hospital Research Institute · Calgary, Alberta and 11 other locations · NCT04448184

• Mind-body program for patients with blood cancers

  This study tests whether a mind-body group program can help people with blood cancers who are in remission manage their fatigue and improve their overall well-being.

  Recruiting Universität Duisburg-Essen · Stuttgart · NCT03735992

• Cognitive training program for survivors of hematopoietic cell transplantation

  This study is testing a brain training program to see if it can help people who have survived hematopoietic cell transplantation think better and improve their memory over 12 weeks.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT03094026

• Registry for evaluating the Precision Medicine Molecular Tumor Board

  This study is testing how genetic testing of tumors can help doctors make better treatment decisions for patients with blood cancers and solid tumors.

  Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT03023202

• Testing genetic markers for early detection of myeloid cancers and bone marrow failure

  This study is testing if looking for specific genetic markers in blood and tissue samples can help find myeloid cancers and bone marrow issues earlier in people who show early signs but aren't diagnosed yet.

  Recruiting at 3 sites Mayo Clinic · Scottsdale, Arizona and 2 other locations · NCT02958462

Related topics

Quick answers

How many Hematologic Neoplasms clinical trials are recruiting right now?

16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 13 countries. The most sites are in United States (8 trials), Denmark (2 trials), Germany (2 trials), Canada (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 3: 3, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →